Your Location:
Home >
Browse articles >
Chinese Medicine Regulating TGF-β 1/Smad Signaling Pathway in Treatment of Diabetic Nephropathy: A Review
Chinese Medicine Regulating TGF-
β 1/Smad Signaling Pathway in Treatment of Diabetic Nephropathy: A Review- Chinese Journal of Experimental Traditional Medical Formulae Vol. 28, Issue 23, Pages: 237-249(2022)
DOI: 10.13422/j.cnki.syfjx.20221308
Scan QR Code
Full Text(HTML)
Figs( 1 ) Tabs( 3 )
References
Publication Info
Metrics
269
Views
75
Downloads
5
CSCD
Alert me when the article has been cited
Submit
Tools
- BibTeXDownload
- EndnoteDownload
- RefMan Download
- NoteExpressDownload
- NoteFirstDownload
Related Articles
Chinese Medicine Regulates NLRP3 Inflammasomes to Treat Diabetic Nephropathy: A Review
Chinese Medicine Regulates Atherosclerosis-related Signaling Pathway: A Review
Intervention of Traditional Chinese Medicine in Diabetic Nephropathy by Regulating Nrf2 Signaling Pathway: A Review
Mechanism of Mitochondrial Autophagy and Intervention of Traditional Chinese Medicine in Renal Fibrosis: A Review
Effect and Mechanism of Modified Sini San on Improving Intestinal Mucosal Barrier of Chronic Stress Rats via Regulating Short-chain Fatty Acid Metabolism and Inhibiting HMGB1/RAGE Signaling Pathway
Related Author
ZHAO Zhe
BAI Min
JIN Yuqiu
TIAN Mengyuan
CHEN Guangshun
LIU Zhenhua
Manli ZHOU
Yanzhen ZHAO
Related Institution
Gansu University of Chinese Medicine
School of Traditional Chinese Medicine(TCM), Hunan University of Chinese Medicine
Hunan Provincial Key Laboratory of Diagnostics of TCM, Hunan University of Chinese Medicine
Nanjing University of Chinese Medicine
Changzhou Hospital of Traditional Chinese Medicine, Nanjing University of Chinese Medicine


